A trio of papers shows that specialized antibodies can direct T cells to destroy cells that display portions of mutant cancer-related proteins, as well as T cells that have become cancerous themselves.
Epidemic may be peaking and could end within three years, scientists suggest; dengue antibodies enhance risk of Zika infection; considering new strategies for the control of mosquito-borne disease outbreaks